Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease

Objective: This study aimed to investigate the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone for patients with stable cardiovascular diseases in the China. Methods: We used TreeAge 2019 to construct a Markov model to assess the direct healthcare costs and quality-adjus...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Tianyu, Zheng, Zhou, Gao, Shang, Xu, Jiaying, Cao, Pen, Jia, Huanhuan, Yu, Xihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251332/
https://www.ncbi.nlm.nih.gov/pubmed/35795549
http://dx.doi.org/10.3389/fphar.2022.921387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251332/
https://www.ncbi.nlm.nih.gov/pubmed/35795549
http://dx.doi.org/10.3389/fphar.2022.921387

Ejemplares similares